A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration
Status:
Unknown status
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The objective of the CABERNET Trial is to evaluate the safety and efficacy of focal delivery
of radiation for the treatment of subfoveal choroidal neovascularization (CNV) associated
with wet age-related macular degeneration (AMD). The Epi-Rad90™ Ophthalmic System treats
neovascularization of retinal tissue by means of a focal, directional delivery of radiation
to the target tissues in the retina. Using standard vitreoretinal surgical techniques, the
sealed radiation source is placed temporarily over the retinal lesion by means of a handheld
medical device.